The Supreme Court of Ghana has unanimously ruled that Alpha Beta Education Centre Limited holds valid title to parcels of land at Dansoman–Akokorfoto in Accra, bringing to a close a land dispute that ...
Aqvesme is expected to be available in late January 2026. The Food and Drug Administration (FDA) has approved Aqvesme™ (mitapivat) for the treatment of anemia in adults with alpha- or beta-thalassemia ...
The complaint details that the bribe was requested to process a refund of N3,310,912, covering shortfalls caused by poorly calculated allowances and discrepancies in currency exchange. Segun ...
Company will host investor conference call and webcast tomorrow, December 24 at 8:00 a.m. ET CAMBRIDGE, Mass., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (AGIO), a commercial-stage ...
What Is Aqvesme, and Why Does It Matter? Aqvesme (mitapivat) is a new oral medicine approved by the FDA for treating anemia in adults with alpha- or beta-thalassemia, including those who need and ...
Pagaya Technologies offers compelling short-term upside, but its high beta exposes it to significant risk in a likely market-wide de-rating within 12 months. Pagaya's second-stage underwriting and API ...
The biggest stories of the day delivered to your inbox.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback